Interpace diagnostics redpath
WebInterpace Diagnostics leverages the latest technology to develop and commercialize novel molecular diagnostic tests. Our tests are designed to detect genetic alterations that are … WebOct 2, 2024 · Interpace Diagnostics. Research Report. Interpace Diagnostics. Research Report. Download PDF Print. Stock Information. October 2, 2024. Current Price: $1.48. Target Price: $5.54. Market Data. Symbol: ... IDXG’s thyroid molecular diagnostic tests (ThyGenX and ThyraMIR thyroid assays) ...
Interpace diagnostics redpath
Did you know?
WebIn light of the foregoing, we’re thrilled to present Interpace Diagnostics. Interpace is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. WebNov 3, 2014 · PARSIPPANY, N.J., Nov. 3, 2014 /PRNewswire/ -- PDI, Inc. , a leading healthcare commercialization company, announced the acquisition of RedPath …
WebApr 20, 2024 · On March 23, 2024 the Company announced that its outstanding secured debt arising from the acquisition of RedPath Integrated Pathology, Inc. in 2014, … WebWHEREAS, PDI and Payee entered into an Agreement and Plan of Merger ( the “Merger Agreement”) dated October 31, 2014 by and among Redpath Integrated Pathology, Inc., …
WebMar 31, 2024 · Indeterminate thyroid nodules (ITN) represent 20–30% of biopsied nodules, with a 10–60% risk of malignancy. Molecular testing can stratify the risk of malignancy among ITNs, and subsequently reduce the need for unnecessary diagnostic surgery. We aimed to assess the performance of these molecular tests at a single … WebFree and open company data on Pennsylvania (US) company Interpace Diagnostics Corporation (company number 3730729), 2515 Liberty Avenue, Pittsburgh, PA, 15222. …
WebMar 23, 2024 · Interpace Diagnostics Group (OTCQX:IDXG) slips 6% premarket on increased volume in response to the deal it struck to restructure its $9.34M debt to RedPath.It sold the debt obligation to an...
WebNov 3, 2014 · The purchase helps PDI subsidiary Interpace Diagnostics expand its oncology product portfolio with RedPath's PathfinderTG platform, which includes … decor for a beach houseWebPancraGEN ® is a unique, DNA-based, integrated molecular pathology test that assesses the risk of cancer in pancreatic cysts, helping you to optimally manage each individual … federal labor laws poster 2021 freeWebMay 11, 2006 · Interpace Diagnostics Corporation a provider in 2515 Liberty Ave Pittsburgh, Pa 15222. Taxonomy code 291U00000X with license number 39D1024654 … federal labor laws regarding payWebNov 10, 2014 · The exit was a result of a sale to PDI, Inc. ("PDI", Nasdaq:PDII) with the RedPath asset operating under PDI's molecular diagnostics division, Interpace … decor for a mantleWebInterpace Biosciences acquires RedPath Integrated Pathology on 2014-11-03 for $12000000. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. … decor for a kitchenWebList of Interpace Biosciences 's 2 Acquisitions, including RedPath Integrated Pathology and Pharmakon. Save Search . Companies Contacts Investors Funding Rounds Acquisitions … federal labor laws regarding breaksWebRedPath Integrated Pathology - Interpace Diagnostics. ... Interpace Diagnostics Clinical Transformation Consultant Highmark Blue Cross Blue Shield Jan ... federal labor laws poster 2022 free